ResMed RMD Cash Flow Statement
| Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | ||
|---|---|---|---|---|---|---|
| $398.73M+9.2% | $392.59M+13.9% | $348.54M+11.9% | $379.71M+29.9% | $365.04M+21.5% | ||
| $58.98M+35.0% | $49.89M+7.4% | $47.7M+6.6% | $63.63M+45.7% | $43.68M+0.5% | ||
| $26.79M+11.1% | $28.94M+27.9% | $21.16M+5.0% | $24.75M+15.7% | $24.12M+18.0% | ||
| $554.13M-4.2% | $339.75M+10.1% | $457.32M+40.5% | $538.77M+22.4% | $578.66M+43.9% | ||
| $33.65M+61.8% | $28.54M+38.2% | $42.97M+141% | $30.59M+22.9% | $20.8M-1.9% | ||
| $24.88M— | —— | $522K— | $138.58M+604% | $0-100% | ||
| -$58.03M-82.6% | -$50.94M-38.8% | -$52.58M-2,550% | -$133.71M-187% | -$31.79M+4.1% | ||
| $87.24M+12.3% | $87.58M+12.7% | $87.75M+12.7% | $77.59M+10.0% | $77.7M+10.2% | ||
| $175.01M+133% | $175.01M+133% | $150.01M+200% | $100.01M+100% | $75.03M+50.1% | ||
| —— | $5M0.0% | $0-100% | $5M-98.3% | $0-100% | ||
| -$255.24M-77.2% | -$258.35M-75.1% | -$230.27M-52.7% | -$163.89M+58.3% | -$144.07M+57.1% | ||
| $243.44M-40.7% | $33.22M-65.2% | $174.4M-7.2% | $276.74M+61,261% | $410.77M+1,385% | ||
| $520.48M-6.7% | $311.21M+8.1% | $414.36M+34.7% | $508.18M+22.4% | $557.87M+46.5% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does ResMed generate?
- ResMed (RMD) generated $1.9B in operating cash flow over the trailing twelve months.
- What is ResMed's free cash flow?
- After $135.7M of capital expenditures, ResMed's free cash flow was $1.8B over the trailing twelve months, up 11.8% year over year.
- Where does ResMed's cash flow data come from?
- Every line is extracted from ResMed's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
